nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Clinical aspects for survivin: a crucial molecule for targeting drug-resistant cancers
|
Singh, Neha |
|
2015 |
20 |
5 |
p. 578-587 10 p. |
artikel |
2 |
Contents page 2
|
|
|
2015 |
20 |
5 |
p. iii- 1 p. |
artikel |
3 |
Contents page 1
|
|
|
2015 |
20 |
5 |
p. i- 1 p. |
artikel |
4 |
Dendrimer generational nomenclature: the need to harmonize
|
Kesharwani, Prashant |
|
2015 |
20 |
5 |
p. 497-499 3 p. |
artikel |
5 |
Discovery and development of DNA methyltransferase inhibitors using in silico approaches
|
Medina-Franco, José L. |
|
2015 |
20 |
5 |
p. 569-577 9 p. |
artikel |
6 |
Intracellular caspase-modulating chimeric antigen receptor
|
Tarone, Scott |
|
2015 |
20 |
5 |
p. 629-634 6 p. |
artikel |
7 |
Investigational new treatments for Clostridium difficile infection
|
Ivarsson, Mattias E. |
|
2015 |
20 |
5 |
p. 602-608 7 p. |
artikel |
8 |
Pharmacological treatment of idiopathic pulmonary fibrosis: an update
|
Spagnolo, Paolo |
|
2015 |
20 |
5 |
p. 514-524 11 p. |
artikel |
9 |
Recent advances in dendrimer-based nanovectors for tumor-targeted drug and gene delivery
|
Kesharwani, Prashant |
|
2015 |
20 |
5 |
p. 536-547 12 p. |
artikel |
10 |
Restoration of mitochondria function as a target for cancer therapy
|
Bhat, Tariq A. |
|
2015 |
20 |
5 |
p. 635-643 9 p. |
artikel |
11 |
Rethinking ‘academic’ drug discovery: the Manchester Institute perspective
|
Jordan, Allan M. |
|
2015 |
20 |
5 |
p. 525-535 11 p. |
artikel |
12 |
Silver nanoparticles: synthesis, properties, and therapeutic applications
|
Wei, Liuya |
|
2015 |
20 |
5 |
p. 595-601 7 p. |
artikel |
13 |
Sources of innovation: an assessment of intellectual property
|
Kinch, Michael S. |
|
2015 |
20 |
5 |
p. 500-504 5 p. |
artikel |
14 |
Targeting key dioxygenases in tryptophan–kynurenine metabolism for immunomodulation and cancer chemotherapy
|
Austin, Christopher J.D. |
|
2015 |
20 |
5 |
p. 609-617 9 p. |
artikel |
15 |
Targeting the Achilles heel of the hepatitis B virus: a review of current treatments against covalently closed circular DNA
|
Ahmed, Marawan |
|
2015 |
20 |
5 |
p. 548-561 14 p. |
artikel |
16 |
Targeting xenobiotic receptors PXR and CAR in human diseases
|
Banerjee, Monimoy |
|
2015 |
20 |
5 |
p. 618-628 11 p. |
artikel |
17 |
The coming of age of engineered multivalent antibodies
|
Nuñez-Prado, Natalia |
|
2015 |
20 |
5 |
p. 588-594 7 p. |
artikel |
18 |
Treat the brain and treat the periphery: toward a holistic approach to major depressive disorder
|
Zheng, Xiao |
|
2015 |
20 |
5 |
p. 562-568 7 p. |
artikel |
19 |
Using transcriptomics to guide lead optimization in drug discovery projects: Lessons learned from the QSTAR project
|
Verbist, Bie |
|
2015 |
20 |
5 |
p. 505-513 9 p. |
artikel |